Did you know?

Comparison Analysis Based on SEC Data. Company Name. Johnson & Johnson. Industry (SIC) 2834 - Pharmaceutical Preparations. Revenue in 2022. $94,943 million (ranked #2 out of 645 companies in the industry) Assets as of 12/31/2022. $187,378 million (ranked #2)View All Zacks #1 Ranked Stocks Johnson & Johnson (JNJ) Quote …Johnson And Johnson's current Dividend, dividend pay out and yield comparisons to industry, sector, and S&P 500

JNJ formed a 1-2-3-4-5 Motive Wave after the neckline was broken. Corrective Wave being formed now. A wave is over. B wave to form this week. C wave may go up to the upper resistance level. Thereafter, JNJ to begin a long downtrend. Neckline of H&S pattern was broken. JNJ formed a 1-2-3-4-5 Motive Wave after the neckline was broken.On the trailing twelve months basis Due to repayements of liabilities of -21.65% Johnson And Johnson decreased Leverage Ratio in the 12 months ending in III Quarter 2023 to 1.29, above the Johnson And Johnson's average Leverage Ratio. Leverage Ratio is the average cumulative value over the last four quarters. Among companies in the Major …Johnson & Johnson Or Novo Nordisk: Which Is The Best Big Pharma Near Cap-Gainer Jun. 16, 2022 5:35 AM ET Johnson & Johnson (JNJ) NVO 11 Comments 9 Likes Peter F. Way, CFAJohnson & Johnson (JNJ) key stats comparison: compare with other stocks by metrics: …Jun 23, 2020 ... Johnson & Johnson exits fairness cream market, but what about competitors? ... Though Johnson & Johnson (J&J), the US healthcare and FMCG giant ...

Jnj contact info: Phone number: (732) 626-5160 Website: www.jnjwarehouse.com What does Jnj do? Since 2003 JNJ has been providing valuable and comprehensive warehousing and distribution services to domestic and international clients.J&J stock price quote (NYSE: JNJ), historical charts, related news, stock analyst insights and more to help you make the right investing decisions.JNJ Segments >> More on JNJ Financial Strength Comparisons >> See JNJ Balance Sheets Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Oct 01 2023 On the trailing twelve months basis Due to debt repayement of -21.65% Johnson And Johnson decreased Leverage Ratio for Trailing Twelve Months Period in … ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Jnj competitors. Possible cause: Not clear jnj competitors.

JNJ’s revenue and EBITDA have grown at respective CAGRs of 6.7% and 8.2% over the past three years. The company’s normalized net income has increased at a CAGR of 11.9% over the same period.Facebook’s Avatars feature, which lets you customize a virtual lookalike of yourself for use as stickers in comments and Messenger chats, is today launching in the U.S. Essentially Facebook’s version of Snap’s Bitmoji, Avatars were first in...

42.65. 33.08. Compare Johnson & Johnson (JNJ) to other companies with price, technicals, performance, and fundamentals comparison.New Brunswick, NJ. 10000+ Employees. 25 Locations. Type: Company - Public (JNJ) Founded in 1887. Revenue: $10+ billion (USD) Biotech & Pharmaceuticals. Competitors: Abbott, Novartis, Covidien Create Comparison. Imagine using your passion and knowledge to change humankind for the better.JNJ Company Profile >> Back to JNJ Fundamentals at a Glance >> Back to JNJ Growth Comparisons Annual Revenue Growth Comment Johnson And Johnson's Annual Revenue for the fiscal year ended 2022, increased by 1.25% to $94,943.00 millions, from $93,775.00 millions achieved a year ago.

range rover defender 2 door The Infiniti QX60 is a luxury midsize SUV that offers a combination of style, performance, and advanced features. When it comes to performance and powertrain options, the Infiniti QX60 holds its own against its competitors. how to read stocks chartsexpensive stocks McNeil Consumer Healthcare, the JNJ subsidiary that markets Tylenol, was responsible for $2.1 billion of company's overall $47 billion in 2004 sales. Therefore, analysts don't expect a sales drop ... ark forecast Johnson & Johnson Common Stock (JNJ) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. nasdaq cetxchickfila franchise feeidv etf McNeil Consumer Healthcare, the JNJ subsidiary that markets Tylenol, was responsible for $2.1 billion of company's overall $47 billion in 2004 sales. Therefore, analysts don't expect a sales drop ... apple stock predictions 2023 The main competitors of Bristol-Myers Squibb include Pfizer (PFE), AbbVie (ABBV), Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Sanofi (SNY), GSK (GSK), Takeda Pharmaceutical (TAK), and Abbott Laboratories (ABT). These companies are all part of the "pharmaceutical preparations ... financial planning software companiesportfolio asset management softwarejames bound car A. The latest price target for Johnson & Johnson ( NYSE: JNJ) was reported by Morgan Stanley on Monday, April 10, 2023. The analyst firm set a price target for 179.00 expecting JNJ to rise to ...Roughly 53 percent of sales came from abroad. Competitive advantage: Product: The first competitive advantage for JNJ lies in its product itself which has "NO MORE TEARS" formula patent. Safety, comfort, and gentleness have always been a top most priority in its products.